Table 2.
Univariate and multivariate analysis for OS in 90 patients removing the impact of HSCT.
| Variable | Univariate | Multivariate | |||||
|---|---|---|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | c-index | vif | nomo score | |
| Age at diagnosis (45y) | 7.087 (3.332-15.07) | 3.66E-07 | 8.018 (3.272-19.649) | 5.32E-06 | 0.792 | 1.237466 | 0/100 |
| TP53 and cell cycle | 4.464 (1.69-11.79) | 2.53E-03 | 4.294 (1.558-11.834) | 0.00484 | 1.015417 | 0/51 | |
| LDH (600U/L) | 1.803 (0.8758-3.711) | 0.11000 | 3.630 (1.599-8.237) | 0.00205 | 1.248115 | 0/42 | |
| Response in D19-BMR detection (M1+M2/M3) | 3.78 (1.814-7.877) | 3.85E-04 | 3.185 (1.440-7.045) | 0.00422 | 1.090931 | 0/48 | |